Approval Probability
TA Base Rate
Adjusted LOA
ML Risk
Also known as Acidform 5 g
Acidform · 1 trial · 1 indication
Vaginal swabs were used to collect samples from the vagina of women dosed with Acidform, HEC placebo, or no treatment. The pH of the samples was measured at pre-determined time points over the course of 7 days.
| Arm | Type | Description |
|---|---|---|
| Acidform Gel, Group A | EXPERIMENTAL | Administration of a single vaginal dose of Acidform gel (5 g) |
| Acidform Gel, Group B | EXPERIMENTAL | Administration of a single vaginal dose of Acidform gel (4 g) |
| Acidform Gel, Group C | EXPERIMENTAL | Administration of a single vaginal dose of Acidform gel (3 g) |
| Placebo Gel, Group D | PLACEBO_COMPARATOR | Administration of a single dose of hydroxyethylcellulose (HEC) placebo gel (4 g) |
| No intervention, Group E | NO_INTERVENTION | No vaginal product administered |
| Name | Type | Description |
|---|---|---|
| Acidform 5 g | DRUG | Effect of 5 g vaginally administered Acidform on pH over 7 days |
| Placebo 4 g | DRUG | Effect of 4 g of vaginally administered HEC placebo gel on pH over 7 days |
| Acidform 4 g | DRUG | Effect of 4 g vaginally administered Acidform on pH over 7 days |
| Acidform 3 g | DRUG | Effect of 3 g vaginally administered Acidform on pH over 7 days |
Inclusion Criteria: 1. Healthy female subjects between 18 and 45 years, inclusive 2. Ability to understand the consent process and procedures 3. Subjects agree to be available for all study visits 4. Written informed consent in accordance with institutional guidelines 5. Negative pregnancy test 6. ...